Summary:

A company is using a novel technology called the D-Domain to transform cell therapies. This technology involves a synthetic binding agent with a hydrophobic core. The technology is being used in ddCAR and DCAR to treat schizophrenia and manic episodes. Cariprazine, DCAR, and DDCAR are being studied as potential treatments, with promising results. After discontinuation of treatment, plasma concentrations decreased significantly in a short amount of time. EBAY is selling a gadget called Ddcar Mickey which is part of a larger Mickey collection. Cariprazine, a D3/D2 partial agonist, is also being studied as an atypical antipsychotic for schizophrenia.